NCT07467330 2026-03-12
Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment
Fujian Cancer Hospital
Phase 3 Recruiting
Clinical Trials
26 trialsNCT05316181 2026-02-12
KOV-HIPEC-02R
National Cancer Center, Korea
Phase 3 Active not recruiting
NCT01279135 2026-02-06
PARCER
Tata Memorial Hospital
Phase 3 Completed
NCT05177484 2026-01-30
PICoC
The Royal Wolverhampton Hospitals NHS Trust
Phase 3 Completed
NCT07332221 2026-01-12
Application of Toripalimab as Adjuvant Therapy After Esophageal Cancer Surgery: A Multicenter Clinical Trial
Henan Cancer Hospital
Phase 3 Not yet recruiting
NCT07323589 2026-01-07
Impact of Myo-Inositol Alone vs Myo-Inositol Plus Metformin on Conception, Adherence, and Tolerability in PCOS
PAEC general hospital
Phase 3 Completed
NCT07047456 2025-12-23
Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT
Anhui Provincial Hospital
Phase 3 Recruiting
NCT03784014 2025-12-11
MULTISARC
Institut National de la Santé Et de la Recherche Médicale, France
Phase 3 Active not recruiting
NCT06520163 2025-12-04
Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma
The Affiliated People's Hospital of Ningbo University
Phase 3 Recruiting
NCT06476639 2025-11-28
ANVU
Queensland Centre for Gynaecological Cancer
Phase 3 Not yet recruiting
NCT06940947 2025-11-20
ETHOS
Norwegian Department of Health and Social Affairs
Phase 3 Recruiting
NCT03136445 2025-10-28
TREATT
NHS Blood and Transplant
Phase 3 Completed
NCT04776655 2025-10-02
LIBImAb
Azienda USL Reggio Emilia - IRCCS
Phase 3 Recruiting
NCT07185672 2025-09-22
PReCedeNT
Tata Memorial Hospital
Phase 3 Recruiting
NCT05236946 2025-09-10
Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT
Tata Memorial Hospital
Phase 3 Recruiting
NCT05278052 2025-09-10
TARGET-02
Tata Memorial Hospital
Phase 3 Recruiting
NCT06793917 2025-07-20
Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma
Fujian Cancer Hospital
Phase 3 Recruiting
NCT07068464 2025-07-16
ICRA
NHS Grampian
Phase 3 Not yet recruiting
NCT07050043 2025-07-03
LEDANG
Hospital Sultanah Bahiyah
Phase 3 Recruiting
NCT02446652 2025-05-29
Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer
National Institute of Cancerología
Phase 3 Withdrawn
NCT06156514 2025-05-28
MICHELE
National Institute of Cancerología
Phase 3 Recruiting
NCT04328948 2025-05-22
ARMADILLO
National Cancer Center, Japan
Phase 3 Recruiting
NCT04785768 2025-05-22
IV PCA With or Without Continuous Dose vs Oral Opioid to Maintain Analgesia for Severe Cancer Pain After Successful Titration
Fujian Cancer Hospital
Phase 3 Completed
NCT01785420 2025-04-09
Pre Operative Trastuzumab in Operable Breast Cancer
Tata Memorial Hospital
Phase 3 Recruiting
NCT01916317 2025-04-09
Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer
Tata Memorial Hospital
Phase 3 Active not recruiting
NCT03168880 2025-04-09
TNBC
Tata Memorial Hospital
Phase 3 Active not recruiting